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Abstract 
The overwhelming majority of people with chronic obstructive pulmonary disease (COPD) have 
at least one co-existing medical condition often conceptualized as ‘comorbidities’. These co-
existing conditions vary in severity and impact; it is likely that for some patients, COPD is not 
their most important or severe condition. The concepts of multimorbidity and frailty may be 
useful to understand the broader needs of people with COPD undergoing pulmonary 
rehabilitation. Multimorbidity describes the co-existence of two or more chronic conditions, 
without reference to a primary condition. Best care for people with multimorbidity has been 
described as a shift from providing disease-focused to patient-centred care. Pulmonary 
rehabilitation is well placed to deliver such care as it focuses on optimizing function, encourages 
integration across care settings, values input from multidisciplinary teams and measures patient-
important outcomes. When designing optimal pulmonary rehabilitation services for people with 
multimorbidity, the concept of frailty may be useful. Frailty focuses on impairments, rather than 
medical conditions including impairments in mobility, strength, balance, cognition, nutrition, 
endurance, mood and physical activity. Emerging data suggest that frailty may be modifiable 
with pulmonary rehabilitation. The challenge for pulmonary rehabilitation clinicians is to 
broaden our perspective on the role and outcomes of pulmonary rehabilitation for people with 
multimorbidity. 
  
Introduction 
It is uncommon to meet an individual with chronic obstructive pulmonary disease (COPD) who 
does not have at least one other chronic health condition. Amongst Medicare beneficiaries in the 
United States, 18% of individuals with COPD have one to two co-existing conditions, 30% have 
three to four co-existing conditions and 49% have five or more1. Amongst those referred for 
pulmonary rehabilitation, the proportion of patients with at least one co-existing condition varies 
from 51% to 96% 2. Co-existing conditions have important implications for outcomes in COPD. 
People with co-existing diabetes, hypertension or cardiovascular disease have increased risk of 
hospitalization and all-cause mortality compared to those with COPD alone, with greater risks in 
those with more severe lung disease 3. Similarly, depression and anxiety are associated with a 
greater risk of readmission to hospital and mortality following a COPD exacerbation 4, 5.  
In recent years several studies have addressed the impact of co-existing medical conditions on 
the outcomes of pulmonary rehabilitation for people with COPD, with some showing a positive 
impact and others a negative one. For example, for people with COPD and cardiometabolic 
disease, pulmonary rehabilitation outcomes have been reported as better by Walsh and 
colleagues 6 but worse by other groups 7, 8. Similarly, mood disturbance may either increase 9 or 
decrease 8 the likelihood of clinically significant gains with rehabilitation. There are also varying 
conclusions regarding the impact of obesity on pulmonary rehabilitation outcomes 10, 11. This 
variability may arise in part from the complexity of participants in modern pulmonary 
rehabilitation programs, who have co-existing conditions of varying severity and impact. All 
these studies have assumed that as participants in pulmonary rehabilitation, COPD is the primary 
and most important of the co-existing conditions; it is possible that for some patients their other 
health conditions are more important or more severe. In some instances pulmonary rehabilitation 
may not have met the broader needs of individual participants with significant co-existing health 
challenges.  
Frailty is a concept that relates to comorbidity. Unlike comorbidity that focuses on medical 
conditions, frailty focuses on the impairments regardless of the conditions. Markers of frailty 
could include impairments in mobility, strength, balance, cognition, nutrition, endurance, mood 
and physical activity 12-14. Individuals with COPD and other chronic conditions often have 
impairments affecting numerous systems and are therefore more likely to meet the criteria for 
frailty.  
Given that it is common for pulmonary rehabilitation candidates to have multiple chronic 
conditions, it is increasingly likely that many of their important clinical problems will not be 
directly related to respiratory disease. People with COPD have expressed their preference for 
individualized models of care that target the clinical problems they perceive to be most important 
15. In this paper we will discuss how we could broaden our perspective on the role and outcomes 
of pulmonary rehabilitation, with particular reference to the concepts of multimorbidity and 
frailty. 
 
Multimorbidity vs comorbidity - does the label matter? 
Traditionally, co-existing conditions have been described using the term ‘comorbidity’, defined 
as the presence of one or more additional disorders co-occuring with a primary disorder, which 
in this case is COPD. However such a definition pre-supposes that one condition is ‘primary’ and 
remains so over time. More recently, the term multimorbidity has been used to describe co-
existence of two or more chronic conditions in the same individual, without reference to a 
primary condition 16. The concept of multimorbidity acknowledges that chronic conditions may 
overlap; may vary in severity; and may change in importance or burden over time. A conceptual 
framework comparing comorbidity and multimorbidity in a typical patient who might present to 
pulmonary rehabilitation is presented in Figure 1. For this individual at this particular time, 
COPD is not the dominant problem and there is interaction between co-existing chronic 
conditions; this is better reflected by a multimorbidity model. Multimorbidity is now the most 
common chronic condition experienced by adults, affecting almost three in four individuals aged 
65 years and older 16. It is heavily influenced by health inequalities, occurring 10-15 years earlier 
in those who live in more deprived areas compared to those who live in the most affluent areas 
17. Individuals with multimorbidity are at greater risk of adverse outcomes and treatment 
complications than their individual conditions would confer; are more likely to receive 
ineffective care; have higher health care costs; and have worse survival 18, 19. 
Delivery of health care to people with multimorbidity is challenging and not well supported by 
clinical practice guidelines. This was well illustrated in 2005 in a paper which detailed the 
application of the most recent clinical guidelines to a hypothetical 79-year-old woman with 
osteoporosis, osteoarthritis, type 2 diabetes mellitus, hypertension and COPD 20. The five 
relevant disease-specific clinical practice guidelines recommended 12 separate medications, 
taken in 19 doses on five occasions throughout the day, as well as 14 non-pharmacological 
activities, some of which were contradictory (for example weightbearing exercise for 
osteoporosis vs non-weightbearing exercise for type 2 diabetes with peripheral neuropathy). 
Such a treatment regimen is unlikely to be safe, effective or efficient, and its burden is unlikely 
to promote adherence. Only two of the five clinical practice guidelines directly addressed 
multimorbidity. More recently, qualitative studies have described dispiriting experiences of care 
for people with multimorbidity. Patients and carers report poor communication with and between 
health care providers; a lack of care coordination; long wait times for services; difficulty making 
decisions about health care; being unsure how to prioritise; and feeling alone (21). Family 
physicians described poor communication and lack of care coordination across services; 
concerns regarding the ability of patients to adhere to complex treatment regimens; difficulty 
quantifying the harms and benefits of guideline-directed care; concerns regarding adverse events 
when following multiple guidelines; unrealistic expectations of patients and families; and 
insufficient time or reimbursement to deal with the complexities of multimorbidity in everyday 
practice 21, 22. 
Whilst important efforts are underway to make evidence-based care more accessible to people 
with multimorbidity 23, current guidelines do not meet the challenges of multimorbidity and as a 
result, pulmonary rehabilitation clinicians still face significant challenges. A review of seven 
recent guidelines relevant to rehabilitation for people with chronic disease 24-30 reveals that three 
guidelines do not mention co-existing conditions, whilst another three guidelines make only 
passing mention of minor program adaptations such as commencing exercise training at low 
workloads and progressing slowly, or being as physically active as possible. The most extensive 
discussion is in the American Thoracic Society / European Respiratory Society pulmonary 
rehabilitation statement 24 which suggests additions to existing assessments to improve safety 
and efficacy (eg use of cardiopulmonary exercise test and electrocardiograms, assessment of 
anxiety and depression); use of specialized equipment, particularly for bariatric patients; and 
modifications to exercise prescription for those who cannot tolerate the usual training protocols, 
including consideration of interval training and inspiratory muscle training. Broadening of 
education for pulmonary rehabilitation providers is suggested, to ensure recognition of relevant 
signs and symptoms across a broad range of chronic conditions. The authors conclude that 
further research is needed, to better understand pulmonary rehabilitation outcomes in this group. 
This recommendation reflects the paucity of clinical trial data in pulmonary rehabilitation for 
patients with multimorbidity. Analysis of studies included in a recent Cochrane review of 
pulmonary rehabilitation for COPD 31 reveals that out of 65 randomized controlled trials, 51% 
excluded people with cardiac disease and 48% excluded those with musculoskeletal disease 
(Figure 2), conditions that are present in 43% and 42% of people with COPD respectively 23. It 
will remain difficult for clinical guideline developers and clinicians to adequately address 
multimorbidity whilst there is insufficient research to guide their decisions. 
 
Why pulmonary rehabilitation is well placed to improve outcomes for people with 
multimorbidity 
Providing best care for people with multimorbidity has been described as a shift from disease-
focused interventions to patient-focused care: 
‘To align with the clinical reality of multimorbidity, care should evolve from a disease 
orientation to a patient goal orientation, focused on maximizing the health goals of 
individual patients with unique sets of risks, conditions, and priorities’ 16(page 2494).  
This involves identifying patient and family goals and preferences for care; identifying disease-
related and other modifiable barriers to goal achievement, including social and environmental 
circumstances; understanding and communicating the likely effect of treatments on goal 
attainment; and facilitating shared decision making. 
In practical terms, best care for people with multimorbidity has the following features: 
• Focussed on optimizing function  
• Measures patient-centred outcomes 
• Avoids inappropriate, excessive and non-beneficial care 
• Ensures integration and coordination across disease conditions  
• Ensures integration between clinicians and settings of care 
• Has coordinated input from multidisciplinary health care teams, assembled to meet each 
patient’s needs 16, 18. 
 
These features will be familiar to health professionals in pulmonary rehabilitation. Pulmonary 
rehabilitation programs have always had a strong focus on improving function, and measurement 
of patient-important outcomes is considered essential to best practice care 24, 32. Pulmonary 
rehabilitation programme coordinators frequently assume a role in care coordination, ensuring 
that members of the multidisciplinary team are appropriately involved to meet the needs of 
individual patients. Recently, pulmonary rehabilitation has been acknowledged as a core 
component of integrated care for people with COPD24, 33. However to date, these activities have 
occurred within a respiratory disease framework. To ensure that we are well equipped to provide 
patient-centred care to the growing number of individuals with multimorbidity, broader thinking 
may be required.  
A key shift in thinking might be around how we describe, assess and measure outcomes for 
patients undergoing pulmonary rehabilitation. For patients with COPD, severity of disease is 
frequently described in terms of forced expiratory volume in one second (FEV1) or GOLD stage; 
assessments and outcome tools are frequently disease specific (eg Chronic Respiratory Disease 
questionnaire, St George’s Respiratory Questionnaire) or may not adequately describe the range 
of functional impairments experienced by people with multimorbidity (eg 6-minute walk test or 
incremental shuttle walk test). New measurement tools that accurately describe the range of 
impacts on physical, psychological and social function in people with multimorbidity are needed, 
to guide patient-centred care. An ideal measurement tool for patients with multimorbidity would 
be applicable regardless of underlying diagnoses; sensitive to changes with pulmonary 
rehabilitation; relevant across other settings of care; capture patient-important outcomes; and 
facilitate shared decision making about best care for the individual 18. The concept of frailty and 
its associated measurement tools has the potential to provide such a comprehensive assessment 
for patients with multimorbidity in pulmonary rehabilitation. 
 
What is frailty? 
A consensus on the definition of frailty does not currently exist. In the geriatric literature, 
physical frailty is based on a definition provided by “the interventions on frailty working group” 
including mobility, strength, balance, motor processing, cognition, nutrition, endurance and 
physical activity 12. Until recently, frailty had not been considered in individuals with COPD, 
now two main models appear to exist. Frieds’ five markers of frailty focus on the physiological 
components of frailty including; gait speed, weight loss, exhaustion, grip strength and physical 
activity 13. Gobbens et als’ definition of frailty is dynamic and multi-dimensional, describing 
frailty as a decline in one or more domains of human function. Specifically, Gobbens et al noted 
that frailty also includes psychological and social elements in additional to physical factors 14. 
Frailty is not dependent on the underlying diagnosis; is common in people with respiratory 
disorders, especially those with co-existing medical conditions; and describes key elements of 
function, many of which are addressed by pulmonary rehabilitation. As a result, measures of 
frailty may be useful to describe, assess and measure outcomes in pulmonary rehabilitation 
programs for individuals with comorbidities.,  
 
Frailty in COPD 
On average, 11% of community-dwelling older persons are classified as frail 34. Although frailty 
is associated with aging, individuals with COPD have a twofold increase in prevalence of frailty 
compared to their ‘healthy’ elderly counterparts 35. In individuals with COPD living in the 
community, the prevalence of frailty has been reported to be 58% 36. As those enrolled in PR 
often present with co-existing chronic conditions, the prevalence of frailty may even be higher. 
In a recent study, over 60% of patients attending a PR program were reported to exhibit some 
level of frailty 37. Indeed, a key component of frailty is suggested to be a reduction in exercise 
capacity and those referred to PR nearly always complain of reduced exercise tolerance. 
 
There are likely a number of factors contributing to the increased prevalence of frailty in 
individuals with COPD. The high prevalence of multimorbidity is a key factor - co-existing 
conditions including diabetes, peripheral vascular disease, heart failure and osteoarthritis are also 
associated with an increased prevalence of frailty 14, 38-41. Loss of muscle mass is an important 
contributor to frailty 13 and peripheral muscle weakness is common in those with COPD as a 
likely consequence of systemic inflammation or the use of corticosteroids 13, 42, 43. The 
debilitating nature of COPD also affects an individuals’ ability to remain physically active 44 and 
reductions in physical activity levels have been associated with an increase in frailty prevalence 
45. Both peripheral muscle strength and physical activity are further impacted following an acute 
exacerbation 46-48. Acute exacerbations, defined as an increase in symptoms, become increasingly 
common as the disease progresses and as such, they are likely to contribute to the process of 
frailty. Self-reported shortness of breath has been shown to be the greatest predictor of frailty 36 
and frailty is associated with a reduction in peak oxygen consumption 49.  
 
Consequences of frailty 
Individuals who are recognized as frail have a marked reduction in activities of daily living, 
increased healthcare utilization 36 and are at a greater risk of mortality 50. In fact, frailty increases 
the risk of long-term (12 years) mortality by 80% in individuals with COPD compared to 34% in 
those without COPD 50. In addition, findings from a recent qualitative study describe the 
frustration and fear felt by older, frail people at the prospect of losing their independence, 
highlighting the impact of frailty on psychological wellbeing 51.  
 
Assessment of frailty 
Multi-component assessment: 
It is now readily acknowledged that the assessment of frailty needs to include multiple 
components. Three multi-component assessments have been applied in COPD including Frieds’ 
definition of frailty 37, 52, the Frailty Staging System 50 and the Tilburg Frailty Indicator 53. 
 
Frieds’ five markers of frailty: Frieds’ model focuses on the physical aspect of frailty. The model 
includes five criteria displayed in Table 1. Individuals who meet two of these five criteria are 
defined as pre-frail and those who meet three are classified as frail. According to Fried and 
colleagues, those classified as pre-frail are at an elevated risk for falls, disability, death and 
hospitalization but three items had greater predictive power for these adverse outcomes 13.   
 
The Frailty Staging System: An alternative measure of frailty is the Frailty Staging System (FSS) 
54 consisting of domains of function: visual function, hearing function, arm and leg function, 
urinary continence, nutritional status, mental state, depression, activities of daily living (ADL), 
home environment and social support. Individuals are classified as frail or not frail in each 
domain, a score of one is given when the function is lost. This tool was designed to be a 
pragmatic assessment of frailty that could be easily applied within the clinical setting and it was 
designed to be flexible in-terms of the targets to be assessed and the manner in which assessment 
is conducted. Galizia et al 50 applied seven domains of the FSS in individuals with COPD which 
are displayed in Table 2). These authors further classified the severity of frailty into mild, 
moderate and severe. Those who were classified as frail in one domain were considered to be 
mild, those who were classified as frail in 2 or 3 domains were classified as moderate and people 
who had a loss of function in 4 or more domains were considered severe. The risk or mortality 
was highest in those who were classified as severely frail 50. 
 
The Tilburg Frailty Indicator: The Tilburg Frailty Indicator developed by Gobbens et al (2010) 
includes physical, psychological and social domains 14, 53. Physical frailty is assessed via eight 
questions, four questions ask about psychological wellbeing and three questions are assigned to 
the social domain. Individuals can answer yes, sometimes or no and the maximum score able to 
be obtained is 15. A score of five or greater is indicative of frailty.  
 
Park et al 36 used this framework to assess frailty in individuals with self-reported COPD. Data 
was taken from the NHANES survey and as not all the criteria included in the Tilburg Frailty 
Indicator were available (e.g. balance, endurance, mood, coping), frailty was assessed using nine 
criteria across the three domains (Table 3). Frailty assessed using these nine criteria provided a 
total frailty score, which was found to demonstrate internal consistency (.66). A cut off point of 2 
was used to define frailty. Those individuals with COPD identified as being frail had greater 
disabilities 36. 
 
Single –item assessment of frailty 
The application of a multi-component model of frailty can be considered cumbersome, especially 
in a busy clinical setting and there has been an increasing focus on identifying single-item 
assessments that may be used as surrogate markers of frailty. To date, the most frequent factors 
used in the assessment of frailty in older adults include; gait speed, physical function and 
cognition 55. In individuals with COPD the value of gait speed and physical activity as indicators 
of frailty have been considered.  
 
Gait Speed: Gait speed, defined as the time it takes to walk a short distance, takes very little time 
and space to assess. It is a component of Frieds’ five factors of frailty and has been associated 
with a number of important health outcomes in elderly individuals including; hospitalizations 56, 
57, falls 58 and mortality 59.  
 
Usual gait speed over four metres (4MGS) provides a global assessment of functional capacity in 
community dwelling adults. The test involves walking a 4-metre course at ‘usual’ walking speed, 
from a standing start. The test is performed twice without resting between repetitions and the 
faster time is used to calculate the 4MGS in metres/second 60. A gait speed less than 
0.8metres/second is considered ‘slow’ and has been associated with adverse health outcomes 59. 
The 4MGS has good convergent validity with the 6MWT (r=0.77-0.82) 61. Importantly, 4MGS 
has been shown to be an indicator of future readmissions in individuals with COPD following an 
acute exacerbation 62. The 4MGS is responsive to improvements with pulmonary rehabilitation, 
with the largest effects seen in patients with the slowest gait speed (effect size 1.0) and evidence 
of a ceiling effect in those with well preserved gait speed (effect size 0.2) 63.  
 
To date, the only measure of gait speed to be directly compared with a multi-component 
assessment of frailty in individuals with COPD is 100-foot walk time. One hundred-foot walk 
time has been applied in a population undergoing pulmonary rehabilitation and was found to be a 
good indicator of physical frailty assessed using Frieds’ five factors 52. The test was shown to be 
responsive to pulmonary rehabilitation at six weeks with a mean increase of 8.4m per minute 
observed, although no additional improvement was detected at week 12 52.  
 
Physical activity: A low level of physical activity, assessed using the Minnesota leisure time 
activity questionnaire, is one of Fried’s five markers for frailty. Recently Valenza et al have 
modified the Fried critieron and re-classified low physical activity in individuals with COPD as 
<150min/week 45. Physical activity levels less than this threshold were identified using the 
Baecke physical activity questionnaire, which includes items about household activities, sport, 
and leisure time activities with values less than nine considered to be sedentary. A total physical 
activity score of 3.54 and 3.88 respectively for individuals following an acute exacerbation and 
for those with stable COPD was reported to be predictive of frailty 45.  
 
Recently, objectively measured physical activity has been included as part of a multi-component 
assessment of frailty, however a deficit in this domain alone was not indicative of clinical frailty 
36. A multi-component assessment of frailty, including low levels of physical activity defined as 
less than 85.35 counts per min assessed using the Actigraph (ActiGraph Model 7164 
accelerometer, LLC; Ft. Walton Beach, FL), has had some success in predicting greater 
healthcare utilization 36.  
 
How does frailty impact on pulmonary rehabilitation? 
Pulmonary rehabilitation targets many of the components of frailty, including slowness, 
weakness, fatigue and physical inactivity. To date there has been little exploration of the utility 
of frailty measures in pulmonary rehabilitation, or whether rehabilitation can alter frailty. One 
study from the United Kingdom examined 816 individuals with COPD who were assessed for 
outpatient pulmonary rehabilitation and found that 26% met Fried’s criteria for frailty 64. Those 
with frailty had twice the odds of program non-completion compared to their non-frail 
counterparts (adjusted odds ratio 2.2, 95% confidence interval 1.39 to 3.46). However 
individuals with frailty who completed pulmonary rehabilitation (defined as undertaking 50% of 
planned sessions) had better outcomes than non-frail individuals for exercise performance, 
subjectively measured physical activity, symptoms and health status. More than 60% of program 
completers who were assessed as frail at baseline were no longer frail at the end of pulmonary 
rehabilitation. A reduction in frailty following rehabilitation was also seen in a smaller study 
(n=41), however results were less consistent, perhaps because of the smaller sample size 52.  
 
It is not yet known whether reductions in frailty following pulmonary rehabilitation can be 
sustained over time, or whether these reductions impact on health outcomes such as hospital 
admission and mortality. It is notable that only 55% of frail individuals were able to complete an 
outpatient program; this signals a clear need for new ways to support individuals with complex 
needs to attain the benefits of pulmonary rehabilitation.  
 
How can pulmonary rehabilitation meet the needs of individuals with multimorbidity in 
the future? 
A patient-focused approach to multimorbidity in pulmonary rehabilitation might have the 
following features: 
Broad inclusion criteria: admission to a pulmonary rehabilitation program should be based on 
symptoms, function limitation and consideration of frailty. Diagnosis provides useful 
information, but should be a secondary criterion when considering eligibility. Co-existing health 
conditions should not exclude individuals from pulmonary rehabilitation, except where there are 
concerns regarding the safety of exercise. Referrals and history taking in pulmonary 
rehabilitation should acknowledge the impact of multimorbidity on patient symptoms, function 
and presence of frailty. 
Goal focused: Patient and family goals and preferences for care must be central to program 
design and outcome assessment. Effective goal setting is critical to rehabilitation practice and is 
not a new concept in pulmonary rehabilitation 65, but is even more critical if there is to be an 
explicit focus on patient-centred care. 
Modular approach to rehabilitation content: pulmonary rehabilitation includes exercise training 
education and behavior change 24; beyond this the ideal program content is not known. In the 
context of multimorbidity, the content of a patient-centred pulmonary rehabilitation program will 
vary. Pulmonary rehabilitation practitioners need to feel comfortable proving rehabilitation for 
impairments in other systems beyond respiratory, targeting the components of frailty. This is 
likely to require a sound understanding of rehabilitation for heart failure, cancer and 
musculoskeletal disorders, as well as appropriate structures to provide psychological and social 
support. Membership of the multi-disciplinary team should be determined by the needs of the 
individual patient, rather than ideology or tradition. For instance, the diabetes educator or pain 
specialist may be a key team member in some cases. Financial and other incentives should be 
considered to ensure that delivery of pulmonary rehabilitation directly addresses patient goals 
and measures whether these goals are achieved. 
Broader training for pulmonary rehabilitation practitioners: As suggested in the ATS/ERS 
pulmonary rehabilitation statement 24, broader training will be required for health professionals 
delivering pulmonary rehabilitation. This will ensure that important symptoms of co-existing 
conditions are recognized and can be adequately addressed. Pulmonary rehabilitation 
practitioners need an in-depth understanding of the role and nature of rehabilitation across a 
range of chronic diseases, as well as sophisticated skills in adapting the exercise component to 
address individual patient needs and goals. Training in goal setting will be essential for all new 
pulmonary rehabilitation practitioners. 
Outcome assessment aligned with individual goals and preferences: Whilst respiratory-specific 
outcomes are excellent for capturing respiratory symptoms such as dyspnea and cough, other 
important domains such as fatigue may not be adequately covered. Concepts such as frailty may 
be useful to understand and measure the impacts of multiple health conditions upon individuals, 
regardless of underlying diagnoses. The Multiple Chronic Conditions Measurement Framework 
18 proposes an individualized measurement framework for people with multimorbidity. As well 
as measures of health and wellbeing, other important process measures for the care of people 
with multimorbidity can be included such as the degree of care coordination, the extent of 
shared-decision making and the cost of care. 
Ensure pulmonary rehabilitation research reflects patient populations: Whilst research that 
includes patients with more diverse characteristics is bigger, messier and more complex, it better 
reflects the patients who are admitted to pulmonary rehabilitation programs. Both researchers 
and funders should explicitly consider multimorbidity when new trials are proposed. Patients 
who are frail (eg with slow gait speeds) should not be excluded from pulmonary rehabilitation 
trials. 
Clinical practice guidelines: Recently, important efforts have been made to highlight important 
considerations for pulmonary rehabilitation in people with mulitmorbidity 24, however further 
advances are needed in this area. Future clinical guidelines should consider multimorbidity early 
in the document development process, directly address it where possible including statements 
regarding confidence in treatment effects for common co-existing conditions, acknowledge cost-
benefit trade-offs that may influence treatment decisions, and outline gaps where future research 
is needed. 
 
Pulmonary rehabilitation - so what’s in a name? 
There is ample evidence that pulmonary rehabilitation is a highly successful intervention, 
delivering meaningful improvements for patients with respiratory disease, their communities and 
the health system. We should not give it up in favour of an untested, generic model of 
rehabilitation. The challenge is not in the name of pulmonary rehabilitation; the challenge is for 
our model to evolve, building on existing successes to more comprehensively address the needs 
of people with multimorbidity. This presents an exciting opportunity to place pulmonary 
rehabilitation at the forefront of person-centred care. 
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Table 1: Frieds’ five markers of frailty  
 
Item Type of measure  Criteria 
Weight Loss Direct measurement of weight Unintentional loss of ≥10 pounds in the 
previous year. 
Weakness Handheld dynamometer Maximum grip strength (kilograms) of the 
dominant hand adjusted for gender and 
body mass index (BMI). (For example, a 
male with a BMI of 26.1-26 would require 
grip strength at least 30kg to be defined as 
not frail). 
Exhaustion Two questions taken from the 
Center for Epidemiological 
Studies – Depression scale 
(CES-D) (‘I felt that everything 
I did was an effort’ and ‘I 
could not get going’). 
A score of 2 or 3 (felt this way for a 
moderate amount of the time in the last 
week (3-4 days) or most of the time). 
Physical activity Minnesota leisure time activity 
questionnaire 
Kcals per week expended are calculated 
using standardized algorithm and stratified 
by gender. Men with Kcals of physical 
activity per week less than 383 are frail 
and women with Kcals per week less than 
270 are frail. 
Slowness (or gait 
speed) 
15 foot walk test Time taken to walk 15 feet adjusting for 
gender and standing height. (For example, 
a female with height greater than 159cm 
would be required to walk 15 feet in 6 
seconds or less to be identified as not 
frail). 
 
  
Table 2: The Frailty Staging System as applied by Galizia et al., 2011 
 
Item  Type of measure Criteria 
Visual function Self-report Could not recognize a friend across the 
street. 
Hearing function Self-report Need people to raise their voices to hear 
and understand them. 
Mobility Self-report Having great difficulty or being unable to 
walk around the house, walk outside, 
climb stairs or walk half a mile. 
Urinary function Self-report Total incontinence 
Cognitive 
function 
Mini Mental State Examination 
(MMSE) 
A score less than 24 
Disability Basic Activities of Daily 
Living (BADL) 
Need assistance with at least one BADL 
Social support Social support scale used in an 
elderly population (Mazella et 
al 2010). 
A score of 13-17 
 
  
 Table 3: The Tilburg Frailty Indicator as applied by Park et al., 2013. 
 
Item Type of measure Criteria 
Physical frailty Nutrition A direct measure of 
weight 
Unintentional weight loss of more than 
10 pounds over the previous year. 
Mobility Self-report Difficulty walking without any special 
equipment or having at least moderate 
difficulty walking up 10 steps. 
Physical 
activity 
Actigraph 
(ActiGraph Model 
7164 accelerometer, 
LLC; Ft. Walton 
Beach, FL) 
Less than 85.35 counts per minute. 
 
 
Strength Self-report Some difficulty carrying or lifting 
something weighing 10 pounds. 
Vision Self-report Poor vision, even when wearing 
corrective eyewear. 
Hearing Self-report Moderate trouble hearing without a 
hearing aid. 
Psychological 
frailty 
Cognition Self-report Difficulties in remembering or 
experiencing periods of confusion 
Social frailty Social Self-report Not having anyone to provide emotional 
support support. 
Social 
relations 
Self-report Having no close friends.  
 
 
  
Figure 1. Concepts of comorbidity and multimorbidity. 
Comorbidity refers to co-existing chronic conditions, whereas multimorbidity acknowledges that 
there may not be a ‘dominant’ problem, that conditions interact and vary in severity, importance 
and burden. 
COPD – chronic obstructive pulmonary disease; HT – hypertension; OA – osteoarthritis; OP – 
osteoporosis; T2DM – type 2 diabetes mellitus. 
 
 
  
Figure 2. Top five exclusion criteria in randomised controlled trials of pulmonary 
rehabilitation. 
Data from McCarthy et al (2015). 
 
 
 
 
 
 
